Disc Medicine Inc美股招股说明书(2025-01-21版)
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
Clearmind Medicine Inc 2025年年度报告和过渡报告
Annex 1 Socio-Economic Analysis Of the potential restriction of the perand polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products
3D MEDICINES二零二三年年报
3D MEDICINES二零二三年中期报告
Harnessing the Benefits of Externally Controlled Clinical Trials (ECTs) to Accelerate Development of Better Medicines
3D MEDICINES-B二零二二年年报
Position on the Use of Artificial Intelligence in the Medicinal Product Lifecycle
Disc Medicine Inc美股招股说明书(2025-01-23版)
公众号
小程序
社群